Pretreatment with FK506 Improves Survival Rate and Gas Exchange in Canine Model of Acute Lung Injury
Authors:
- 1 January 2001
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 163 (1) , 79-84
Abstract
The novel effects of FK506 on shock induced by lipopolysaccharide and phorbol myristate acetate (LPS/PMA) were studied using beagles. Five groups were studied: endotoxin shock control group (both 0.5 mg/kg of LPS and 30 μ g/kg of PMA, n = 6); methylprednisolone-treated endotoxin shock group (n = 5); FK506-treated endotoxin shock groups in which intravenous infusions of FK506 at 2.5 μ g/kg/h (low dose, n = 5), 8 μ g/kg/h (medium dose, n = 5), and 25 μ g/kg/h (high dose, n = 5) were administered. In the control group, the survival rate was 33%. Also, arterial hypoxemia, systemic hypotension, and marked increases in pulmonary vascular resistance (PVR) and wet-to-dry weight ratio (W/D) were observed. FK506 treatment at both medium and high doses significantly attenuated these LPS/PMA-induced physiological changes, and the survival rates were 80 and 100%, respectively. On the other hand, in the methylprednisolone group, no obvious effects were observed. The present study suggests that FK506 could have prophylactic potential against acute lung injury in endotoxin shock.Keywords
This publication has 19 references indexed in Scilit:
- Augmentation of endotoxin-induced pulmonary responses by mononuclear cell phagocytosis in the reticuloendothelial systemCritical Care Medicine, 1996
- Locally Produced Tumor Necrosis Factor-α Mediates Interleukin-2Induced Lung InjuryCirculation Research, 1996
- Inhibition by FK506 of formyl peptide-induced neutrophil activation and associated protein synthesisBiochemical Pharmacology, 1994
- Interleukin-2-induced lung injury. The role of complement.Circulation Research, 1994
- Attenuation of the pulmonary vascular response to endotoxin by a thromboxane synthesis inhibitor (UK-38485) in unanesthetized sheepJournal of Surgical Research, 1991
- Tumor Necrosis Factor-α Mediates Acid Aspiration-induced Systemic Organ InjuryAnnals of Surgery, 1990
- Haemodynamic effects induced by intravenous administration of high doses of r-Met Hu IL-2 [ala-125] in patients with advanced cancerIntensive Care Medicine, 1990
- Interleukin-2 Administration Causes Reversible Hemodynamic Changes and Left Ventricular Dysfunction Similar to Those Seen in Septic ShockChest, 1988
- Cyclosporine A enhances platelet aggregationKidney International, 1987
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985